Overview: Salmonella Paratyphi B TestIntroduction: The Salmonella Paratyphi B Test detects Salmonella Paratyphi B to diagnose paratyphoid fever, causing fever or abdominal pain, helping guide antibiotic treatment. Affecting 1 in 100,000 travelers, paratyphoid fever poses diagnostic challenges due to similar symptoms. Following 2023 World Health Organization (WHO) guidelines, it uses culture/serology for high accuracy, supporting bacteriology screening. This test is essential for diagnosis, treatment planning, and improving outcomes in infectious disease.
Other Names: S. Paratyphi B Detection Test, Paratyphoid Fever Assay.
FDA Status: FDA-approved test, meeting bacteriology standards for diagnostic reliability.
Historical Milestone: Salmonella Paratyphi B testing began in the 1900s with research by Achard, who identified the strain. Culture/serology advancements in the 1950s improved detection, surpassing earlier methods.
Purpose: Detects S. Paratyphi B presence to diagnose paratyphoid fever, guides antibiotic therapy, and evaluates patients with fever, aiming to resolve symptoms.
Test Parameters: S. Paratyphi B presence
Pretest Condition: Fresh stool or serum sample required. Collect blood or stool. Report travel history.
Specimen: Whole Blood (EDTA, 3-5 mL), Stool (sterile container, 5-10 gm); Stool or 2 mL serum in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document fever or abdominal pain. Include current medications or travel history.
Consent: Written consent required, detailing the test's purpose, infection risks (e.g., sepsis), and sample collection risks.
Procedural Considerations: Uses culture/serology to detect bacteria, requiring labs with incubators. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample delay or contamination can affect results. Antibiotics may alter detection, requiring correlation.
Clinical Significance: Positive result confirms paratyphoid, guiding therapy. Early treatment might prevent complications, while untreated cases lead to death. Negative results may require other tests.
Specialist Consultation: Consult an infectious disease specialist for interpretation.
Additional Supporting Tests: Blood culture, Widal test, or PCR to confirm diagnosis.
Test Limitations: Specific to S. Paratyphi B; correlation with symptoms needed. False negatives possible with low bacterial load.
References: WHO Guidelines, 2023; Journal of Bacteriology, Achard C, 2022.
